Frailty subtypes among people living with HIV and HIV-negative individuals in Taizhou, Zhejiang: a cluster analysis
-
摘要:
目的 识别HIV阳性和阴性衰弱者衰弱类型并探索其分布和流行病学特征差异,以便为HIV阳性衰弱者采取的干预提供依据。 方法 选取2017年2月-2020年1月台州市“HIV与衰老相关疾病前瞻性队列研究”(the comparative HIV and aging research in Taizhou cohort, CHART)基线数据中符合Fried衰弱表型标准的HIV阳性和阴性衰弱者,对五项衰弱问题进行潜类别聚类分析。 结果 83例HIV阳性衰弱者和101例阴性衰弱者被聚成三类(第一类:低体力活动、疲惫和握力差为特点的无力状,即无力组;第二类:以低步速为突出特点的五项功能差,即低步速组;第三类:体重减少和轻度无力状,即消瘦组)。HIV阳性衰弱者在低步速组中占比较高,为54.2%,阴性衰弱者在无力组中占比较高,为35.6%。HIV阳性衰弱者低步速组现在吸烟比例高于消瘦组(χ2 =10.889, P=0.004),无力组现在吸烟比例高于消瘦组(χ2 =7.909, P=0.019),消瘦组偏瘦比例高于无力组(χ2 =9.309, P=0.009)。阴性衰弱者无力组≥60岁比例高于消瘦组(χ2 =10.502, P=0.001),睡眠障碍患病率低于消瘦组(χ2 =6.541, P=0.011);低步速组≥60岁比例高于消瘦组(χ2 =6.232, P=0.013)。 结论 HIV阳性和阴性衰弱者衰弱类型构成不同,HIV阳性衰弱者表现为以低步速为突出特点的五项功能差。应结合其特征进行干预。 Abstract:Objective To identify the frailty subtypes and investigate their differences in distribution and epidemiological characteristics between people living with HIV (PLWH) and HIV-negative individuals, to provide evidence for conducting intervention on frail PLWH. Methods PLWH and HIV-negative individuals who met the Fried's frailty phenotype criteria were selected from the baseline survey of the comparative HIV and aging research in Taizhou cohort (CHART) from February 2017 to January 2020. Latent cluster analysis was conducted to identify the frailty subtypes based on five Fried frailty components. Results Among 83 frail PLWH and 101 frail HIV-negative individuals included, three frailty clusters were identified. Cluster 1 was characterized by weakness with low physical activity, exhaustion and weak grip strength, which was defined as weakness group; cluster 2 was characterized by 5 poor items with slow walking pace as prominent feature, which was defined as slow walking pace group; cluster 3 was characterized by weight loss and mild weakness, which was defined as emaciation group. Proportion of frail PLWH was the highest in slow walking pace group (54.2%), but proportion of frail HIV-negative individuals was the highest in weakness group(35.6%). Frail PLWH in slow walking pace group were more likely to be current smokers compared with those in emaciation group(χ2 =10.889, P=0.004). Frail PLWH in weakness group were more likely to be current smokers compared with those in emaciation group(χ2 =7.909, P=0.019). Frail PLWH in emaciation group were more likely to be underweight compared to those in weakness group(χ2 =9.309, P=0.009). Frail HIV-negative individuals in weakness group were more likely to be aged over 60 years old compared to those in emaciation group(χ2 =10.502, P=0.001), but less likely to have sleep disorders than those in emaciation group(χ2 =6.541, P=0.011). Frail HIV-negative individuals in slow walking pace group were more likely to be aged over 60 years old compared to those in emaciation group(χ2 =6.232, P=0.013). Conclusions Distribution of frailty subtypes are different between frail PLWH and HIV-negative individuals. Frail PLWH have more frailty subtype characterized by 5 poor components with slow walking pace as the prominent feature. Screening and intervention should be actively carried out considering frailty subtypes and their characteristics in PLWH. -
Key words:
- AIDS /
- Frailty /
- Sleep disorders /
- Depressive symptoms /
- Comorbidity
-
表 1 2017年2月-2020年1月浙江省台州市HIV阳性和阴性衰弱者的衰弱表型基本特征差异[n(%)]
Table 1. The basic characteristics of frailty subtypes among frail people living with HIV and HIV-negative individuals in Taizhou, Zhejiang Province fron February 2017 to January 2020 [n(%)]
变量 HIV阳性衰弱者 HIV阴性衰弱者 合计
(n=83)无力组
(n=19)低步速组
(n=45)消瘦组
(n=19)χ2/F/H值 P值 合计
(n=83)无力组
(n=19)低步速组
(n=45)消瘦组
(n=19)χ2/F/H值 P值 年龄组(岁) 7.357 0.025a 12.907 0.002a < 60 39(47.0) 12(63.2) 15(33.3) 12(63.2) 25(24.7) 4(11.1) 5(16.7) 16(45.7) ≥60 44(53.0) 7(36.8) 30(66.7) 7(36.8) 76(75.3) 32(88.9) 25(83.3) 19(54.3) 年龄
[M (P25, P75), 岁]62.4
(45.5, 70.0)51.5
(32.4, 64.4)67.3
(55.7, 75.3)54.0
(37.9, 66.2)17.597 < 0.001 b 69.8
(60.0, 76.1)72.8
(65.7, 77.1)72.2
(65.6, 80.1)60.3
(51.0, 71.3)13.624 0.001a 性别 0.320 0.936 0.051 0.975 女 18(21.7) 4(21.0) 9(20.0) 5(26.3) 25(24.7) 9(25.0) 7(23.3) 9(25.7) 男 65(78.3) 15(79.0) 36(80.0) 14(73.7) 76(75.3) 27(75.0) 23(76.7) 26(74.3) 文化程度 3.075 0.215 0.601 0.741 文盲/小学 54(65.1) 10(52.6) 33(73.3) 11(57.9) 79(78.2) 29(80.6) 22(73.3) 28(80.0) 初中及以上 29(34.9) 9(47.4) 12(26.7) 8(42.1) 22(21.8) 7(19.4) 8(26.7) 7(20.0) BMI (kg/m2) 9.292 0.041a 3.589 0.485 < 18.5 23(27.7) 1(5.3) 13(28.9) 9(47.4) 5(5.0) 0(0.0) 3(10.0) 2(5.7) 18.5~ < 24.0 46(55.4) 15(78.9) 24(53.3) 7(36.8) 45(44.5) 17(47.2) 13(43.3) 15(42.9) ≥24.0 14(16.9) 3(15.8) 8(17.8) 3(15.8) 51(50.5) 19(52.8) 14(46.7) 18(51.4) 腰臀比 0.107 0.948 4.011 0.135 正常 46(55.4) 11(57.9) 25(55.6) 10(52.6) 29(28.7) 6(16.7) 11(36.7) 12(34.3) 超标 37(44.6) 8(42.1) 20(44.4) 9(47.4) 72(71.3) 30(83.3) 19(63.3) 23(65.7) 吸烟 11.689 0.016 a 2.670 0.615 从不 38(45.8) 7(36.8) 16(35.6) 15(79.0) 56(55.5) 17(47.2) 18(60.0) 21(60.0) 以前吸 25(30.1) 7(36.8) 17(37.8) 1(5.3) 23(22.8) 8(22.2) 7(23.3) 8(22.9) 现在吸 20(24.1) 5(26.4) 12(26.6) 3(15.7) 22(21.7) 11(30.6) 5(16.7) 6(17.1) 睡眠障碍 0.991 0.609 6.559 0.038 a 否 33(39.8) 9(47.4) 18(40.0) 6(31.6) 42(41.6) 20(55.6) 13(43.3) 9(25.7) 是 50(60.2) 10(52.6) 27(60.0) 13(68.4) 59(58.4) 16(44.4) 17(56.7) 26(74.3) 抑郁症状得分
[M (P25, P75)]18.0
(14.0, 21.0)18.0
(14.0, 20.0)17.0
(14.0, 20.0)20.0
(15.0, 24.0)1.110 0.334 14.0
(11.0, 18.0)12.5
(10.5, 16.5)14.0
(11.0, 16.0)17.0
(14.0, 21.0)10.610 0.005 b 共病数量(种) 3.060 0.559 6.061 0.195 0 38(45.8) 10(52.6) 18(40.0) 10(52.6) 16(15.8) 9(25.0) 1(3.3) 6(17.1) 1 26(31.3) 7(36.8) 14(31.1) 5(26.3) 35(34.7) 12(33.3) 12(40.0) 11(31.4) ≥2 19(22.9) 2(10.6) 13(28.9) 4(21.1) 50(49.5) 15(41.7) 17(56.7) 18(51.5) HIV诊断时间(年) 2.232 0.317 < 3 67(80.7) 14(73.7) 39(86.7) 14(73.7) ≥3 16(19.3) 5(26.3) 6(13.3) 5(26.3) 抗病毒治疗时间(年) 7.554 0.113 未治疗 27(32.5) 4(21.1) 20(44.4) 3(15.8) < 3 42(50.6) 10(52.6) 19(42.2) 13(68.4) ≥3 14(16.9) 5(26.3) 6(13.4) 3(15.8) 当前CD4+T淋巴细胞计数(个/μl) 3.107 0.212 < 200 52(62.7) 15(79.0) 27(60.0) 10(52.6) ≥200 31(37.3) 4(21.0) 18(40.0) 9(47.4) 当前HIV病毒载量(copies/ml)(n=48) 6.493 0.045a < 200 30(62.5) 10(83.3) 12(46.2) 8(80.0) ≥200 18(37.5) 2(16.7) 14(53.8) 2(20.0) 注:a表示P < 0.05;b表示P < 0.001。 表 2 2017年2月-2020年1月浙江省台州市HIV阳性和阴性衰弱者的衰弱类型分布
Table 2. The distribution of frailty subtypes among frail people living with HIV and HIV-negative individuals in Taizhou, Zhejiang Province fron February 2017 to January 2020
HIV感染状态 无力组 低步速组 消瘦组 χ2值 P值 HIV(+) 19 (22.9) 45 (54.2) 19 (22.9) 11.343 0.003 a HIV(-) 36 (35.6) 30 (29.7) 35 (34.7) 合计 55 (29.9) 75 (40.8) 54 (29.3) 注:a表示P < 0.05。 -
[1] Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci, 2001, 56(3): M146-M156. DOI: 10.1093/gerona/56.3.m146. [2] Kelly SG, Wu K, Tassiopoulos K, et al. Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease, and diabetes among aging adults with human immunodeficiency virus[J]. Clin Infect Dis, 2019, 69(8): 1370-1376. DOI: 10.1093/cid/ciy1101. [3] Ding Y, Lin H, Liu X, et al. Higher prevalence of frailty among a sample of HIV-infected middle-aged and older Chinese adults is associated with neurocognitive impairment and depressive symptoms[J]. J Infect Dis, 2017, 215(5): 687-692. DOI: 10.1093/infdis/jix032. [4] Verheij E, Kirk GD, Wit FW, et al. Frailty is associated with mortality and incident comorbidity among middle-aged human immunodeficincy virus(HIV)-positive and HIV-negative participants[J]. J Infect Dis, 2020, 222(6): 919-928. DOI: 10.1093/infdis/jiaa010. [5] Paul RH, Cooley SA, Garcia-Egan PM, et al. Cognitive performance and frailty in older HIV-positive adults[J]. J Acquir Immune Defic Syndr, 2018, 79(3): 375-380. DOI: 10.1097/qai0000000000001790. [6] Guaraldi G, Malagoli A, Theou O, et al. Correlates of frailty phenotype and frailty index and their associations with clinical outcomes[J]. HIV Med, 2017, 18(10): 764-771. DOI: 10.1111/hiv.12527. [7] Smit E, Wanke C, Dong K, et al. Frailty, food insecurity, and nutritional status in people living with HIV[J]. J Frailty Aging, 2015, 4(4): 191-197. DOI: 10.14283/jfa.2015.50. [8] Liu LK, Guo CY, Lee WJ, et al. Subtypes of physical frailty: latent class analysis and associations with clinical characteristics and outcomes[J]. Sci Rep, 2017, 7: 46417. DOI: 10.1038/srep46417. [9] Lin H, Ding Y, Ning C, et al. Age-specific associations between HIV infection and carotid artery intima-media thickness in China: a cross-sectional evaluation of baseline data from the CHART cohort[J]. Lancet HIV, 2019, 6(12): e860-e868. DOI: 10.1016/s2352-3018(19)30263-2. [10] 中国肥胖问题工作组数据汇总分析协作组. 我国成人体重指数和腰围对相关疾病危险因素异常的预测价值: 适宜体重指数和腰围切点的研究[J]. 中华流行病学杂志, 2002, 23(1): 5-10. DOI: 10.3760/j.issn:0254-6450.2002.01.003.Cooperartive Meta-analysis Group of China Obesity Task Force. Predictive value of body mass index and waist circumference to risk factors of related diseases in Chinese adult population[J]. Chin J Epidemiol, 2002, 23(1): 5-10. DOI: 10.3760/j.issn:0254-6450.2002.01.003. [11] 孙长颢. 营养与食品卫生学[M]. 第6版. 北京: 人民卫生出版社, 2007.Sun CH. Nutrition and food hygiene[M]. 6th ed. Beijing: People's Medical Publishing House, 2007. [12] 苏健, 覃玉, 沈冲, 等. 吸烟和戒烟行为与男性2型糖尿病血糖控制关系的研究[J]. 中华流行病学杂志, 2017, 38(11): 1454-1459. DOI: 10.3760/cma.j.issn.0254-6450.2017.11.003Su J, Qin Y, Shen C, et al. Association between smoking/smoking cessation and glycemic control in male patients with type 2 diabetes[J]. Chin J Epidemiol, 2017, 38(11): 1454-1459. DOI: 10.3760/cma.j.issn.0254-6450.2017.11.003. [13] Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research[J]. Psychiatry Res, 1989, 28(2): 193-213. DOI: 10.1016/0165-1781(89)90047-4. [14] Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research[J]. J Clin Epidemiol, 1988, 41(4): 313-321. DOI: 10.1016/0895-4356(88)90138-2. [15] Zung WW. A self-rating depression scale[J]. Arch Gen Psychiatry, 1965, 12: 63-70. DOI: 10.1001/archpsyc.1965.01720310065008. [16] 中华医学会糖尿病学分会. 《中国高血压防治指南》(基层版)委员会. 中国高血压防治指南: 2009年基层版[M]. 北京: 人民卫生出版社, 2010: 19.Chinese Diabetes Society. Writing Group of Chinese Guidelines for the Management of Hypertension (Basic Edition). Chinese guidelines for the management of hypertension: 2009 Basic Edition[M]. Beijing: People's Medical Publishing House, 2010: 19. [17] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018(4): 292-344. DOI: 10.19538/j.nk2018040108.Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition)[J]. Chin J Pract Intern Med, 2018(4): 292-344. DOI: 10.19538/j.nk2018040108. [18] National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266. http://www.ncbi.nlm.nih.gov/pubmed/11904577?dopt=Abstract [19] 邱皓政. 潜在类别模型的原理与技术[M]. 北京: 教育科学出版社, 2008.Qiu HZ. Latent class modeling: Principles and techniques[M]. Beijing: Educational Science Publishing House, 2008. [20] Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults[J]. JAMA, 2011, 305(1): 50-58. DOI: 10.1001/jama.2010.1923. [21] 宋倩, 孟文文, 姜威, 等. 社区老年人步速、握力与跌倒风险的前瞻性队列研究[J]. 中华保健医学杂志, 2020, 22(3): 112-114. DOI: 10.3969/j.issn.1674-3245.2020.03.003.Song Q, Meng WW, Jiang W, et al. Association between gait speed, grip strength and the risk of falls among the elderly in community[J]. Chin J Heal Care Med, 2020, 22(3): 112-114. DOI: 10.3969/j.issn.1674-3245.2020.03.003. [22] Masters MC, Perez J, Tassiopoulos K, et al. Gait speed decline is associated with hemoglobin A1C, neurocognitive impairment, and black race in persons with HIV[J]. AIDS Res Hum Retroviruses, 2019, 35(11-12): 1065-1073. DOI: 10.1089/aid.2019.0101. [23] Gao X, Zhang Y, Saum KU, et al. Tobacco smoking and smoking-related DNA methylation are associated with the development of frailty among older adults[J]. Epigenetics, 2017, 12(2): 149-156. DOI: 10.1080/15592294.2016.1271855. [24] Kahraman T, Ozdogar AT, Abasiyanik Z, et al. Associations between smoking and walking, fatigue, depression, and health-related quality of life in persons with multiple sclerosis[J]. Acta Neurol Belg, 2020. DOI: 10.1007/s13760-020-01341-2. [25] Guaraldi G, Malagoli A, Calcagno A, et al. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65-74 years and more than 75 years[J]. BMC Geriatr, 2018, 18(1): 99. DOI: 10.1186/s12877-018-0789-0.